Article Contents ::
- 1 Details About Generic Salt :: Fulvestr
- 2 Main Medicine Class:: Antiestrogen
- 3 (fool-VESS-trant) Faslodex Solution for injection 50 mg/mL Class: Antiestrogen Indications Treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Contraindications Pregnancy; hypersensitivity to the drug or any component of the product. Route/Dosage Adults: IM 250 mg into buttock at 1-mo intervals. Interactions None well documented. Lab Test Interferences None well documented. Adverse Reactions CNS: Headache; dizziness; insomnia; paresthesia; depression; anxiety. DERMATOLOGIC: Rash; sweating. EENT: Pharyngitis. GI: Nausea; vomiting; constipation; diarrhea; abdominal pain; anorexia. GU: Urinary tract infection. HEMATOLOGIC: Anemia. RESPIRATORY: Dyspnea; increased cough. OTHER: Back pain; hot flushes; bone pain; arthritis; asthenia; pain; transient pain and inflammation at injection site; vasodilation; pelvic pain; peripheral edema; chest pain; flu-like syndrome; fever; accidental injury. Precautions Pregnancy: Category D. Lactation: Undetermined. Children: Safety and efficacy not established. PATIENT CARE CONSIDERATIONS Administration/Storage For IM administration only. Not for IV, SC, or ID administration. Administer prescribed dose once monthly using prefilled syringe(s) and supplied safety needle(s). Administer as single 5 mL injection or concurrent 2.5 mL injections into buttock. Administer injection slowly. Do not administer if cloudiness or particulate matter is noted. Store prefilled syringes in refrigerator (36° to 46°C). Assessment/Interventions Obtain patient history, including drug history and any known allergies. Note history of liver function impairment, bleeding diatheses, thrombocytopenia, or concurrent use of anticoagulants. Ensure that patient has negative pregnancy test before starting therapy. Monitor patient for GI, CNS, general body side effects, and injection site reactions. Inform health care provider if noted and significant. Patient/Family Education Explain name, dose, action, and potential side effects of drug. Advise patient that medication will be prepared and administered by health care provider in a health care setting on a monthly basis. Instruct patient to inform health care provider if any of the following symptoms occur: intolerable nausea, vomiting, constipation, diarrhea, stomach pain, headache, hot flushes, injection site pain or inflammation. Instruct patient to not take any prescription or otc medications or dietary supplements unless advised by health care provider. Instruct women to notify health care provider if they become pregnant, plan on becoming pregnant, or are breastfeeding. Advise patient that follow-up visits and laboratory tests will be required to monitor therapy and to be sure to keep appointments.
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Fulvestr
Main Medicine Class:: Antiestrogen
(fool-VESS-trant)
Faslodex
Solution for injection
50 mg/mL
Class: Antiestrogen
Indications Treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Contraindications Pregnancy; hypersensitivity to the drug or any component of the product.
Route/Dosage
Adults: IM 250 mg into buttock at 1-mo intervals.
Interactions
None well documented.
Lab Test Interferences None well documented.
Adverse Reactions
CNS: Headache; dizziness; insomnia; paresthesia; depression; anxiety. DERMATOLOGIC: Rash; sweating. EENT: Pharyngitis. GI: Nausea; vomiting; constipation; diarrhea; abdominal pain; anorexia. GU: Urinary tract infection. HEMATOLOGIC: Anemia. RESPIRATORY: Dyspnea; increased cough. OTHER: Back pain; hot flushes; bone pain; arthritis; asthenia; pain; transient pain and inflammation at injection site; vasodilation; pelvic pain; peripheral edema; chest pain; flu-like syndrome; fever; accidental injury.
Precautions
Pregnancy: Category D. Lactation: Undetermined. Children: Safety and efficacy not established.
PATIENT CARE CONSIDERATIONS
Administration/Storage
- For IM administration only. Not for IV, SC, or ID administration.
- Administer prescribed dose once monthly using prefilled syringe(s) and supplied safety needle(s).
- Administer as single 5 mL injection or concurrent 2.5 mL injections into buttock.
- Administer injection slowly.
- Do not administer if cloudiness or particulate matter is noted.
- Store prefilled syringes in refrigerator (36° to 46°C).
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note history of liver function impairment, bleeding diatheses, thrombocytopenia, or concurrent use of anticoagulants.
- Ensure that patient has negative pregnancy test before starting therapy.
- Monitor patient for GI, CNS, general body side effects, and injection site reactions. Inform health care provider if noted and significant.
Patient/Family Education
- Explain name, dose, action, and potential side effects of drug.
- Advise patient that medication will be prepared and administered by health care provider in a health care setting on a monthly basis.
- Instruct patient to inform health care provider if any of the following symptoms occur: intolerable nausea, vomiting, constipation, diarrhea, stomach pain, headache, hot flushes, injection site pain or inflammation.
- Instruct patient to not take any prescription or otc medications or dietary supplements unless advised by health care provider.
- Instruct women to notify health care provider if they become pregnant, plan on becoming pregnant, or are breastfeeding.
- Advise patient that follow-up visits and laboratory tests will be required to monitor therapy and to be sure to keep appointments.
PATIENT CARE CONSIDERATIONS
Drugs Class ::
(fool-VESS-trant) |
Faslodex |
Solution for injection |
50 mg/mL |
Class: Antiestrogen |
Indications for Drugs ::
Indications Treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Drug Dose ::
Route/Dosage
Adults: IM 250 mg into buttock at 1-mo intervals.
Contraindication ::
Contraindications Pregnancy; hypersensitivity to the drug or any component of the product.
Drug Precautions ::
Precautions
Pregnancy: Category D. Lactation: Undetermined. Children: Safety and efficacy not established.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CNS: Headache; dizziness; insomnia; paresthesia; depression; anxiety. DERMATOLOGIC: Rash; sweating. EENT: Pharyngitis. GI: Nausea; vomiting; constipation; diarrhea; abdominal pain; anorexia. GU: Urinary tract infection. HEMATOLOGIC: Anemia. RESPIRATORY: Dyspnea; increased cough. OTHER: Back pain; hot flushes; bone pain; arthritis; asthenia; pain; transient pain and inflammation at injection site; vasodilation; pelvic pain; peripheral edema; chest pain; flu-like syndrome; fever; accidental injury.
Drug Mode of Action ::
(fool-VESS-trant) |
Faslodex |
Solution for injection |
50 mg/mL |
Class: Antiestrogen |
Drug Interactions ::
Interactions
None well documented.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note history of liver function impairment, bleeding diatheses, thrombocytopenia, or concurrent use of anticoagulants.
- Ensure that patient has negative pregnancy test before starting therapy.
- Monitor patient for GI, CNS, general body side effects, and injection site reactions. Inform health care provider if noted and significant.
Drug Storage/Management ::
Administration/Storage
- For IM administration only. Not for IV, SC, or ID administration.
- Administer prescribed dose once monthly using prefilled syringe(s) and supplied safety needle(s).
- Administer as single 5 mL injection or concurrent 2.5 mL injections into buttock.
- Administer injection slowly.
- Do not administer if cloudiness or particulate matter is noted.
- Store prefilled syringes in refrigerator (36° to 46°C).
Drug Notes ::
Patient/Family Education
- Explain name, dose, action, and potential side effects of drug.
- Advise patient that medication will be prepared and administered by health care provider in a health care setting on a monthly basis.
- Instruct patient to inform health care provider if any of the following symptoms occur: intolerable nausea, vomiting, constipation, diarrhea, stomach pain, headache, hot flushes, injection site pain or inflammation.
- Instruct patient to not take any prescription or otc medications or dietary supplements unless advised by health care provider.
- Instruct women to notify health care provider if they become pregnant, plan on becoming pregnant, or are breastfeeding.
- Advise patient that follow-up visits and laboratory tests will be required to monitor therapy and to be sure to keep appointments.